Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DW3ZG6
|
|||
| Drug Name |
HST5040
|
|||
| Indication | Methylmalonic acidemia [ICD-11: 5C50.E0] | Phase 2 | [1] | |
| Propionic acidemia [ICD-11: 5C50.E0] | Phase 2 | [1] | ||
| Company |
HemoShear Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04732429) A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia Followed by a Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.